StockClub

LXGTF

LXGTFLexington Biosciences, Inc.$ --
Lexington Biosciences, Inc.

Lexington Biosciences, Inc.

LXGTF

$ -

-

Review earnings summary, surprise history, and upcoming forecasts.

wallet
Earnings Summary
Updated: 09/30/2024FY2024 Q3
Revenue
0M CAD
YoY -
Operating Income
-0M CAD
YoY -0.4%
Net Income
-0M CAD
YoY +0.2%
EPS
-0CAD
YoY 0.0%

Revenue

CAD0
FY2022 Q4CAD0
CAD0
Q4
FY2023 Q1CAD0
CAD0
Q1
FY2023 Q2CAD0
CAD0
Q2
FY2023 Q3CAD0
CAD0
Q3
FY2023 Q4CAD0
CAD0
Q4
FY2024 Q1CAD0
CAD0
Q1
FY2024 Q2CAD0
CAD0
Q2
FY2024 Q3CAD0
CAD0
Q3
Actual
CAD0 (-)

Net Income

CAD-117,870
FY2022 Q4CAD-37,007
CAD-37,007
Q4
FY2023 Q1CAD-42,112
CAD-42,112
Q1
FY2023 Q2CAD-107,713
CAD-107,713
Q2
FY2023 Q3CAD-147,247
CAD-147,247
Q3
FY2023 Q4CAD-177,382
CAD-177,382
Q4
FY2024 Q1CAD-35,625
CAD-35,625
Q1
FY2024 Q2CAD-78,399
CAD-78,399
Q2
FY2024 Q3CAD-117,870
CAD-117,870
Q3
Actual
+CAD29,377 (+20.0%)

Surprise History

Actual RevenueAnalyst Estimate
FY2018
Actual:CAD0
FY2018
CAD0
FY2019
Actual:CAD0
FY2019
CAD0
FY2020
Actual:CAD0
FY2020
CAD0
FY2021
Actual:CAD0
FY2021
CAD0
FY2022
Actual:CAD0
FY2022
CAD0
FY2023
Actual:CAD0
FY2023
CAD0

Analyst Estimates

No forecast data